Rain lashed against the panoramic windows of Amelia Vance's forty-second-floor office, blurring the already fading lights of downtown Chicago.  Amelia, CEO of Vance & Sterling Pharmaceuticals, tapped a manicured nail against the cool glass, the rhythmic percussion a counterpoint to the frantic energy buzzing in the room.  Mahogany furniture gleamed under the recessed lighting, casting long shadows that danced with the flickering reflections of the cityscape.  The air, thick with the scent of brewing coffee and impending crisis, crackled with unspoken tension.  Two figures, her COO, David Chen, and her head of legal, Sarah Miller, stood stiffly before her, their faces etched with a mixture of apprehension and exhaustion.  A single document, stark white against the polished surface of her desk, lay between them, the title emblazoned across the top in bold, black letters: "Preliminary Injunction and Cease and Desist Order."
